Apex Formulations Pvt. Ltd. - India
Apex Formulations is an Indian WHO GMP-certified generic pharmaceutical manufacturer (founded 1998) producing 250+ products across four dosage forms in Gujarat and distributing them via merchant exporters to 20+ countries, a PCD network across 17+ Indian states, government tenders, and contract manufacturing.
- Company typePrivate
- Founded1998
- HeadquartersAhmedabad, India
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Apex Formulations Pvt. Ltd. - India does
Apex Formulations Pvt. Ltd. is an Ahmedabad-headquartered, privately held Indian pharmaceutical manufacturer founded in 1998, operating a WHO GMP, GLP, and ISO 9001-2015 certified production facility in Mehsana, Gujarat. The company's core technology is conventional generic pharmaceutical manufacturing across four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — with a 250+ product portfolio spanning cardiovascular, neurological, anti-infective, and metabolic therapeutic categories. It also offers SR and ER modified-release solid oral presentations, capsule variants, suspensions/solutions, and topical dermatologicals. The underlying operations rely on audited manufacturing processes and quality systems rather than proprietary technology platforms, and the firm holds no disclosed patents or trademarks.
The business model is multi-channel B2B distribution built around six revenue streams: (1) international export of 150+ registered products to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS via merchant exporters; (2) domestic distribution through a PCD (Propaganda Cum Distribution) franchise network covering 17+ Indian states; (3) direct supply to State Governments via tender; (4) third-party/contract manufacturing; (5) loan license manufacturing for other brands; and (6) CMO licensing and distribution partnerships internationally. Pricing is not publicly disclosed and is established through direct B2B inquiry. The company employs 100+ qualified staff, holds 10+ industry awards/accreditations, and operates as a single integrated manufacturing entity with no subsidiaries, no external funding history, and no public listing.
Apex Formulations Pvt. Ltd. - India firmographics
Firmographics- Name
- Apex Formulations Pvt. Ltd. - India
- Legal name
- Apex Formulations Pvt. Ltd.
- Website
- https://apexformulations.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Apex Formulations is an Indian WHO GMP-certified generic pharmaceutical manufacturer (founded 1998) producing 250+ products across four dosage forms in Gujarat and distributing them via merchant exporters to 20+ countries, a PCD network across 17+ Indian states, government tenders, and contract manufacturing.
- Ownership category
- akta.pro rank
Apex Formulations Pvt. Ltd. - India industry classification
Industry- Product category
- Generic Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)
- akta.pro secondary industry
- Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
Keywords
Where Apex Formulations Pvt. Ltd. - India is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Apex Formulations Pvt. Ltd. - India business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Domestic Product Sales: Manufacturing and distribution of pharmaceutical finished formulations to the Indian domestic market through PCD business partners across 17+ states
- International Export Sales: Supply of 150+ registered products to 20+ countries through merchant exporters across South East Asia, Africa, Latin/Central America and CIS regions
- PCD Business Partnership: Partnership-based distribution model for marketing pharmaceutical products through PCD (Propaganda Cum Distribution) franchise network
- Third Party Manufacturing: Contract manufacturing services for other pharmaceutical companies requiring manufacturing capabilities
- Government Supply: Supply of pharmaceutical finished formulations to various State Governments through tender/business contracts
- Loan License Business: Manufacturing under loan license arrangements for other pharmaceutical brands
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Apex Formulations Pvt. Ltd. - India product offering
Product offeringCore offering
Apex Formulations manufactures generic pharmaceutical finished formulations in Tablets, Capsules, Liquid Orals, Skin Creams, and Ointments at a WHO GMP, GLP, and ISO 9001-2015 certified facility in Gujarat, India. The company sells its 250+ product portfolio domestically through PCD franchise partners across 17+ Indian states and State Government tenders, and internationally through merchant exporters across 20+ countries. It also provides contract manufacturing (third-party / loan license) services to other pharmaceutical companies.
Product overview
Apex Formulations Pvt. Ltd. is a pharmaceutical manufacturing company established in 1998 that operates as a single unified business rather than a platform-plus-modules architecture. The company manufactures and distributes generic pharmaceutical finished formulations across two primary channels: Export Pharmaceuticals (serving 20+ countries via merchant exporters with 150+ registered products) and Domestic Pharmaceuticals (serving 17+ states in India through PCD businesses and government tenders). The manufacturing portfolio encompasses four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — supported by contract/third-party manufacturing services and loan license arrangements. The company employs over 100 qualified staff and has received 10+ awards and accreditations.
Differentiator
Problem solved
Functional benefit
Products and services
- Export Pharmaceuticals Apex Formulations' international export product line of pharmaceutical finished formulations supplied to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS regions through merchant exporters, comprising 150+ registered products.
- Domestic Pharmaceuticals (India) Apex Formulations' domestic Indian product line of pharmaceutical finished formulations distributed to 17+ states through PCD (Propaganda Cum Distribution) business partners and supplied directly to various State Governments via tender business.
- Tablets Apex manufactures tablet formulations including SR (sustained release), ER (extended release), and standard tablets across therapeutic categories such as cardiovascular, neurological, anti-infective, and metabolic disorders.
- Capsules Apex manufactures capsule formulations for various therapeutic applications, including modified-release and standard capsule presentations.
- Liquid Orals Apex manufactures liquid oral dosage forms including suspensions and solutions for various therapeutic categories.
- Skin Creams and Ointments Apex manufactures topical dermatological products including skin creams and ointments for various therapeutic applications.
- Third Party / Contract Manufacturing Contract manufacturing organization (CMO) and loan license manufacturing services offered by Apex Formulations to other pharmaceutical companies that require manufacturing capacity under WHO GMP certified quality standards.
- Government Tender Supply Direct supply of pharmaceutical finished formulations by Apex Formulations to various State Governments in India through government tender business / public procurement contracts.
Companies that use Apex Formulations Pvt. Ltd. - India
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Apex Formulations Pvt. Ltd. - India technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Apex Formulations Pvt. Ltd. - India partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Merchant ExporterscoreApex has partnered with Merchant Exporters to supply 150+ products registered in more than 20+ countries across South East Asia, Africa, Latin/Central America and CIS regions. This partnership enables international market reach for Apex's generic pharmaceutical products.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Apex Formulations Pvt. Ltd. - India competitors and assessment
Company assessmentDirect peers
- Tirupati Medicare: Indian pharmaceutical manufacturer offering contract manufacturing and generic formulations across dosage forms. Similar CMO-led, multi-dosage-form business profile with domestic and export reach.
- Acme Formulation: Indian generic pharmaceutical manufacturer with similar product portfolio and third-party manufacturing / domestic distribution model. Comparable mid-tier scale, though with less international export presence than Apex.
- Synokem Pharmaceuticals: Indian contract manufacturer and generic formulations producer with strong third-party manufacturing, loan licensing, and domestic franchise distribution — closely mirroring Apex's CMO + PCD + domestic business mix.
- Akums Drugs & Pharmaceuticals: India's largest contract development and manufacturing organization (CDMO) producing a broad range of finished dosage forms. Highly comparable to Apex: WHO GMP certified, multi-dosage-form manufacturer with strong third-party manufacturing and domestic distribution model.
- Unison Pharmaceuticals: Ahmedabad-based Indian generic manufacturer with a similar mid-tier scale, PCD franchise distribution network across Indian states, and focus on domestic + export generics across multiple dosage forms.
Broad incumbents
- Ajanta Pharma: Mid-large Indian generic pharmaceutical company with significant branded-generic presence in emerging markets (Africa, Asia, CIS). Comparable international footprint structure to Apex's 20+ country export reach, though at a larger scale.
- Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with extensive international operations including emerging markets. Comparable export + domestic generic manufacturing business model, though at substantially greater scale than Apex.
- Cipla: Major Indian pharmaceutical incumbent with extensive global footprint, multi-dosage-form manufacturing (including injectables/inhalables), and government-tender business. Comparable in therapeutic breadth and international reach category.
- Cadila Pharmaceuticals (Zydus): One of India's largest integrated pharmaceutical companies with multi-dosage-form manufacturing, WHO GMP facilities, and significant international presence. Broad incumbent operating in the same generic formulation space.
- Mankind Pharma: India's largest domestic-focused generic pharma company with strong franchise/PCD-style distribution. Comparable domestic distribution model via partner networks across Indian states, but with a much larger branded-generic portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Apex Formulations Pvt. Ltd. - India social profiles
Digital presenceApex Formulations Pvt. Ltd. - India financial estimates
Financial estimateRevenue estimate
Valuation estimate
Apex Formulations Pvt. Ltd. - India leadership team
Management profileNumber of profiles
Apex Formulations Pvt. Ltd. - India funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Apex Formulations Pvt. Ltd. - India M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Apex Formulations Pvt. Ltd. - India
What does Apex Formulations Pvt. Ltd. - India do?
Apex Formulations manufactures generic pharmaceutical finished formulations in Tablets, Capsules, Liquid Orals, Skin Creams, and Ointments at a WHO GMP, GLP, and ISO 9001-2015 certified facility in Gujarat, India. The company sells its 250+ product portfolio domestically through PCD franchise partners across 17+ Indian states and State Government tenders, and internationally through merchant exporters across 20+ countries. It also provides contract manufacturing (third-party / loan license) services to other pharmaceutical companies.
Is Apex Formulations Pvt. Ltd. - India a public or private company?
Apex Formulations Pvt. Ltd. - India is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Apex Formulations Pvt. Ltd. - India founded?
Apex Formulations Pvt. Ltd. - India was founded in 1998. It employs 1 to 10 people.
Where is Apex Formulations Pvt. Ltd. - India based?
Apex Formulations Pvt. Ltd. - India is headquartered in Ahmedabad, India, in the Asia region.
How does Apex Formulations Pvt. Ltd. - India make money?
Six revenue lines are on record. Domestic Product Sales are the primary driver. The others are international Export Sales, PCD Business Partnership, third Party Manufacturing, government Supply and loan License Business.
Who are Apex Formulations Pvt. Ltd. - India's main competitors?
Direct peers on record are Tirupati Medicare, Acme Formulation, Synokem Pharmaceuticals, Akums Drugs & Pharmaceuticals and Unison Pharmaceuticals. Broad incumbents are Ajanta Pharma, Aurobindo Pharma, Cipla, Cadila Pharmaceuticals (Zydus) and Mankind Pharma.
Does Apex Formulations Pvt. Ltd. - India have an API?
No public API is recorded for Apex Formulations Pvt. Ltd. - India.
What industry is Apex Formulations Pvt. Ltd. - India in?
Apex Formulations Pvt. Ltd. - India's product category is Generic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAJ, Generic ANDA/Regulatory Affairs & Submissions, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 325412 and its SIC code is 2834.